日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study

用于预测接受伊马替尼辅助治疗的高危胃肠道间质瘤患者无复发生存期的列线图：一项全国性注册研究

期刊:
影响因子:
doi:10.3892/etm.2026.13140
Yeh, Chun-Nan; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Tsai, Hui-Jen
发表日期：2026
文献求助 收藏

Clinical outcomes of gastroenteropancreatic neuroendocrine neoplasms in Taiwan: A multicenter registry study-TCOG T1214 study.

台湾胃肠胰神经内分泌肿瘤的临床结果：一项多中心注册研究——TCOG T1214 研究

期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.70019
Tsai Hui-Jen, Chen Ming-Huang, Wang Hsiu-Po, Hsiao Chin-Fu, Chen Yen-Yang, Chen Jen-Shi, Yang Mei-Due, Tzen Chin-Yuan, Shan Yan-Shen, Bai Li-Yaun, Chan De-Chuan, Chu Pei-Yi, Ho Ching-Liang, Yang Youngsen, Lin Johnson, Lin Hsuan-Yu, Chang Cheng-Shyong, Wang Chuan-Cheng, Hwang Tsann-Long, Chen Li-Tzong
免疫/内分泌
神经科学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Survival of advanced/recurrent gastrointestinal stromal tumors treated with tyrosine kinase inhibitors in Taiwan: a nationwide registry study

台湾地区接受酪氨酸激酶抑制剂治疗的晚期/复发性胃肠道间质瘤患者的生存情况：一项全国性登记研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-12567-1
Tsai, Hui-Jen; Shan, Yan-Shen; Yang, Ching-Yao; Hsiao, Chin-Fu; Tsai, Chung-Hsin; Wang, Chuan-Cheng; Lin, Ming-Tsan; Ting, Chun-Fu; Chan, De-Chuan; Chen, Te-Hung; Yen, Chueh-Chuan; Chen, Yen-Yang; Lin, Hsuan-Yu; Yeh, Ta-Sen; Ho, Ching-Liang; Shieh, Tze-Yu; Bai, Li-Yaun; Hsu, Jun-Te; Chen, I-Shu; Chen, Li-Tzong; Yeh, Chun-Nan
信号转导
发表日期：2024
文献求助 收藏

Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study

NOVEL 研究结果显示，在对伊马替尼耐药或不耐受的慢性期或加速期慢性粒细胞白血病患者中，尼洛替尼在常规临床实践中的安全性和有效性：

期刊:Therapeutic Advances in Hematology
影响因子:3.1
doi:10.1177/2040620718756603
Kuo, Ching-Yuan; Wang, Po-Nan; Hwang, Wen-Li; Tzeng, Cheng-Hwai; Bai, Li-Yaun; Tang, Jih-Luh; Chang, Ming-Chih; Lin, Sheng-Fung; Chen, Tsai-Yun; Chen, Yeu-Chin; Tan, Tran-Der; Hsieh, Chih-Yi; Lin, Chinjune; Lai, Clinton; Miljkovic, Darko; Chang, Cheng-Shyong
白血病
细胞生物学
粒细胞
发表日期：2018
文献求助 收藏